PanGen Biotech Inc (222110) — Free Cash Flow Generation Index

Latest as of June 2025: 0.98x

PanGen Biotech Inc (222110) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of ₩3.16 Billion represents 1% of operating cash flow (₩3.22 Billion). Read PanGen Biotech Inc (222110) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

₩3.16 Billion

KRW

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for PanGen Biotech Inc across 1 annual periods. Explore PanGen Biotech Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for PanGen Biotech Inc (2024–2024)

Year-by-year Free Cash Flow Generation Index for PanGen Biotech Inc. For the full company profile including market capitalisation, see PanGen Biotech Inc market cap and net worth.

Year	FCG Index	Free Cash Flow (KRW)	Operating CF	Capital Expenditures	YoY Change
2024	0.87x	₩2.61 Billion	₩2.99 Billion	₩374.12 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).